Coronary Guidewires Market

Global Coronary Guidewires Market Size, Share and Trends Analysis Report, By Material (Nitinol, Stainless Steel and Others), By Coating (Coated (Hydrophilic, Hydrophobic), and Non-Coated), Forecast (2022-2028)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2026123 | Category : Healthcare Information Technology | Delivery Format: /

The global coronary guidewires market is anticipated to grow at a significant CAGR 5.9% during the forecast period (2022-2028). Coronary guidewires are specialized pieces of equipment. They are used to deliver therapies to diseased areas of the coronary arterial system. These guidewires have the properties of steerability, traceability, flexibility and are used in minimally invasive surgeries. The major factor driving the demand for coronary guidewires is the rising number of minimally invasive surgeries along with the increasing prevalence of cardiovascular diseases (CVDs) across the globe.

According to the World Health Organization (WHO), CVDs are the leading cause of mortality globally with a mortality rate of an estimated 17.9 million people in 2019 which represented 32% of all global mortalities. Additionally, out of these, 85% were due to heart attack and stroke. Furthermore, in the same year, 17 million premature deaths were under the age of 70 due to non-communicable diseases. Hence, the increasing prevalence of CVDs is driving the demand for coronary guidewires which in turn is driving the growth of the market.

Some major players in the market include Abbott Laboratories, Terumo Medical Corp., and Boston Scientific Corp., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2022, Teleflex Inc. announced the clearance of an expanded indication for its specialty catheters and coronary guidewires from the US Food and Drug Administration (FDA). It is used in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI).

Market Coverage

The market number available for – 2021-2028

Base year- 2021

Forecast period- 2022-2028

Segment Covered- 

o By Material

o By Coating

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Abbott Laboratories, Terumo Medical Corp., and Boston Scientific Corp., among others.

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?

How players are addressing challenges to sustain growth?

Where is the investment opportunity?

Global Coronary Guidewires Market Report by Segment

By Material

Nitinol

Stainless Steel

Others

By Coating

Coated

o Hydrophilic

o Hydrophobic

Non-Coated

Global Coronary guidewires Market Report by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa